Risk of venous thromboembolic disease and adequacy of prophylaxis in hospitalized patients in Argentina: a multicentric cross-sectional study

Thrombosis Journal

Esteban Lifschitz⁵  Federico J Capparelli²  Alicia B Vilaseca¹  Enrique Baldessari⁷  Carina Gumpel⁶  Aldo Tabares⁸  Ricardo Watman⁴  Fernando Vazquez³ 

[1] Hematology Department, Clínica San Camilo, Buenos Aires, Argentina;Internal Medicine Department, FLENI, Instituto de Investigaciones Neurológicas Raúl Carrea, Buenos Aires, Argentina;Internal Medicine Department, Hospital Italiano de Buenos Aires, Juan D. Perón 4190, (C1181ACH), Buenos Aires, Argentina;Chief of Medical Policies, Swiss Medical Medicina Privada, Buenos Aires, Argentina;Internal Medicine, Clínica Santa Isabel, National Coordinator of the Thrombosis-Free Area Argentina Program, Buenos Aires, Argentina;Hematology Department, Sanatorio Plaza, Rosario, Argentina;Internal Medicine Department, Hospital Universitario, Fundación Favaloro, Buenos Aires, Argentina;Vascular Medicine and Thrombosis Department, Hospital Privado, Córdoba, Argentina

关键词: Deep vein thrombosis;    Pulmonary embolism;    Adequacy;    Venous thromboembolic disease;    Thromboprophylaxis;    Thrombosis;   

Others  :  834071
DOI  :  10.1186/1477-9560-12-15

 received in 2014-02-18, accepted in 2014-05-25,  发布年份 2014

【 摘 要 】

Background

Venous thromboembolic disease (VTE) is associated with high morbi-mortality. Adherence rate to the recommendations of antithrombotic prophylaxis guidelines (ATPG) is suboptimal. The aim of this study was to describe the adequacy of antithrombotic prophylaxis (ATP) in hospitalized patients as the initial stage of a program designed to improve physician adherence to –ATP recommendations in Argentina.

Methods

This study was a multicenter, cross-sectional study that included 28 Institutions throughout 5 provinces in Argentina.

Results

1315 patients were included, 729 (55.4%) were hospitalized for medical (clinical) reasons, and 586 (44.6%) for surgical reasons. Adequate ATP was provided to 66.9% of the patients and was more frequent in surgical (71%) compared to clinical (63.6%) subjects (p < 0.001). Inadequate ATP resulted from underuse in 76.6% of the patients. Among clinical, 203 (16%) had increased bleeding risk and mechanical ATP was used infrequently.

Conclusions

The adequacy of ATP was better in low VTE risk clinical and surgical patients and high VTE risk in orthopedic patients. There was worse adequacy in high risk patients (with active neoplasm) and in those with pharmacological ATP contraindications, in which the use of mechanical methods was scarce. The adequacy of ATP was greater at institutions with < 150 beds compared with larger institutions. This is the first multicentric study reporting ATP in Argentina. Understanding local characteristics of medical performance within our territory is the first step in order to develop measures for improving ATP in our environment.

【 授权许可】

   
2014 Vazquez et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Hirsh J, Hoak J: Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals. Council on Thrombosis (in consultation with the Council on Cardiovascular Radiology), American Heart Association. Circulation 1996, 93:2212-2245.
• [2]Center for Disease Control and Prevention: AIDS cases, deaths, and persons living with AIDS by year, 1985-2002-United States. MMWR Morb Mortal Wkly Rep 2011, 60:977-1008. Available from: [http://www.cdc.gov/hiv/stats/hasr1402.htm]
• [3]National Institute for Health and Clinical Excellence: Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in inpatients undergoing surgery. NICE clinical guideline No. 46:1–160. Available at: [http://www.nice.org.uk/CG046]. Accessed March 31, 2008
• [4]Society. AC: Breast Cancer Facts & Figures 2003–2004. Available at: [http://wwwcancerorg/docroot/STT/content/STT_1x_Breast_Cancer_Facts_Figures_2003-2004asp] Accessed November 9, 2004
• [5]Pengo V, Lensing AW, Prins MH, Marchiori A, Davidson BL, Tiozzo F, Albanese P, Biasiolo A, Pegoraro C, Lliceto S, Prandoni P: Thromboembolic Pulmonary hypertension study group. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004, 350:2257-2264.
• [6]Kahn SR, Ginsberg JS: Relationship between deep venous thrombosis and the postthrombotic syndrome. Arch Intern Med 2004, 164:17-26.
• [7]Vázquez FJP-MM, Vicens J, González Bernaldo De Quirós F, Giunta DH: Incidence rate of symptomatic venous thromboembolic disease in patients from a medical care program in Buenos Aires, Argentina: a prospective cohort. Thromb J 2013, 11:16. doi:10.1186/1477-9560-11-16 BioMed Central Full Text
• [8]Goldhaber SZ, Tapson VF: A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. Am J Cardiol 2004, 93:259-262.
• [9]Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW: American College of chest physicians. Prevention of venous thromboembolism: American college of chest physicians evidence-based clinical practice guidelines (8th edition). Chest 2008, 133:381S-453S.
• [10]NICE clinical guideline. National Institute of Health and Clinical Excellence: Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in inpatients undergoing surgery. 2008. Accesed March 31, 2008. Avaiable in: [http:/www.nice.org.uk/guidance/CG92]
• [11]Cohen AT, Tapson VF, Bergmann JF, Goldhaber JF, Kakkar AK, Deslandes B, Huang W, Zayaruzny M, Emery L, Anderson FA Jr: Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 2008, 371:387-394.
• [12]Tapson VF, Decousus H, Pini M, Chong BH, Froehlich JB, Monreal M, Spyropoulos AC, Merli GJ, Zotz RB, Bergmann JF, Pavanello R, Turpie AG, Nakamura M, Piovella F, Kakkar AK, Spencer FA, Fitzgerald G, Anderson FA Jr: Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the international medical prevention registry on venous thromboembolism. Chest 2007, 132:936-945.
• [13]Melero MJ, Pagotto VL, Mazzei JA: Venous thromboembolism prevention in non-surgical adult patients admitted in a general hospital. Medicina (B Aires) 2012, 72:361-366.
• [14]Bottaro FJ, Ceresetto JM, Emery J, Bruetman J, Emery N, Pellegrini D, Pironi B, Pineiro G, Fox L, Orrico ME, Palmer S, Prieto S, Bullorsky E: Cross-sectional study of adherence to venous thromboembolism prophylaxis guidelines in hospitalized patients. The Trombo-Brit study. Thromb J 2012, 10:7. BioMed Central Full Text
• [15]Fuzinatto F, Wajner A, Starosta De Waldemar F, De Sousa Hopf JL, Ferro Schuh J, Saldanha Menna Barreto S: Venous thromboembolism prophylaxis in a general hospital. J Bras Pneumol 2011, 37:160-167.
• [16]Guyatt , Eikelboom JW, Gould MK, Garcia DA, Crowther M, Murad MH, Kahn SR, Falck-Ytter Y, Francis CW, Lansberg MG, Akl EA, Hirsh J: Approach to outcome measurement in the prevention of thrombosis in surgical and medical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest physicians evidence-based clinical practice guidelines. Chest 2012, 141:e185S-e194S.
• [17]Gladding P, Larsen F, Durrant H, Black P: Education together with a preprinted sticker improves the prescribing of prophylactic enoxaparin. N Z Med J 2007, 120:1-10.
• [18]Ageno W, Squizzato A, Ambrosini F, Dentali F, Marchesi C, Mera V, Steidl L, Venco A: Thrombosis prophylaxis in medical patients: a retrospective review of clinical practice patterns. Haematologica 2002, 87:746-750.
• [19]Vallano A, Arnau JM, Miralda GP, Pérez-Bartolí J: Use of venous thromboprophylaxis and adherence to guideline recommendations: a cross-sectional study. Thromb J 2004, 2:3. BioMed Central Full Text
• [20]Sutedjo JL, Ng RK, Piazza G, Goldhaber SZ: Medicare’s new regulations for deep vein thrombosis as a “never event”: wise or worrisome? Am J Med 2009, 122:975-976.
• [21]Kucher N, Koo S, Quiroz R, Kooper JM, Paterno MD, Soukonnitov B, Goldhaber SZ: Electronic alerts to prevent thromboembolism among hospitalized patients. N Engl J Med 2005, 352:969-977.
• [22]Goldhaber SZ: Venous thromboembolism prophylaxis: quality, location (hospital vs. Home), and duration. Thromb Haemost 2009, 102:1-2.
• [23]Cohn SL, Adekile A, Mahabir V: Improved use of thromboprophylaxis for deep vein thrombosis following an educational intervention. J Hosp Med 2006, 1:331-338.